[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69532039D1 - Isoxazole - Google Patents

Isoxazole

Info

Publication number
DE69532039D1
DE69532039D1 DE69532039T DE69532039T DE69532039D1 DE 69532039 D1 DE69532039 D1 DE 69532039D1 DE 69532039 T DE69532039 T DE 69532039T DE 69532039 T DE69532039 T DE 69532039T DE 69532039 D1 DE69532039 D1 DE 69532039D1
Authority
DE
Germany
Prior art keywords
group
ring
integer
alkylthio
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69532039T
Other languages
English (en)
Other versions
DE69532039T2 (de
Inventor
Koichi Kojima
Yuichi Aizawa
Isao Kaneko
Junichi Sakai
Masao Kozuka
Kazuo Koyama
Naozumi Samata
Kenji Yoshimi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of DE69532039D1 publication Critical patent/DE69532039D1/de
Application granted granted Critical
Publication of DE69532039T2 publication Critical patent/DE69532039T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69532039T 1994-08-30 1995-08-29 Isoxazole Expired - Fee Related DE69532039T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP20536394 1994-08-30
JP20536394 1994-08-30
JP15057195 1995-06-16
JP15057195 1995-06-16
PCT/JP1995/001714 WO1996006837A1 (fr) 1994-08-30 1995-08-29 Isoxazoles

Publications (2)

Publication Number Publication Date
DE69532039D1 true DE69532039D1 (de) 2003-12-04
DE69532039T2 DE69532039T2 (de) 2004-07-08

Family

ID=26480122

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69532039T Expired - Fee Related DE69532039T2 (de) 1994-08-30 1995-08-29 Isoxazole

Country Status (20)

Country Link
US (2) US5965591A (de)
EP (1) EP0779281B1 (de)
KR (1) KR970705549A (de)
CN (1) CN1098843C (de)
AT (1) ATE253057T1 (de)
AU (1) AU688102B2 (de)
CA (1) CA2198457A1 (de)
CZ (1) CZ290961B6 (de)
DE (1) DE69532039T2 (de)
DK (1) DK0779281T3 (de)
ES (1) ES2208690T3 (de)
FI (1) FI970864A (de)
HK (1) HK1018878A1 (de)
HU (1) HU221138B1 (de)
MX (1) MX9701630A (de)
NO (1) NO308741B1 (de)
NZ (1) NZ291508A (de)
PT (1) PT779281E (de)
RU (1) RU2140414C1 (de)
WO (1) WO1996006837A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ291508A (en) * 1994-08-30 1999-07-29 Sankyo Co Isoxazoles; preparation and medicaments
HUP9900400A3 (en) * 1996-02-27 2001-06-28 Sankyo Company Ltd Chuo Ku Isoxazole derivatives
US6339099B1 (en) * 1997-06-20 2002-01-15 Dupont Pharmaceuticals Company Guanidine mimics as factor Xa inhibitors
AU1616600A (en) * 1998-11-12 2000-05-29 Eli Lilly And Company Aminobenzisoxazole compounds and libraries thereof
US6497928B1 (en) 1999-05-14 2002-12-24 Canon Kabushiki Kaisha Liquid crystal device, mesomorphic functional material and liquid crystal apparatus
US6638981B2 (en) * 2001-08-17 2003-10-28 Epicept Corporation Topical compositions and methods for treating pain
RU2384574C2 (ru) * 2003-12-29 2010-03-20 Сепракор Инк. БЕНЗО[d] ИЗОКСАЗОЛ-3-ОЛЬНЫЕ ИНГИБИТОРЫ DAAO
JP2007517056A (ja) * 2003-12-29 2007-06-28 セプラコア インコーポレーテッド ピロール及びピラゾールｄａａｏ阻害剤
US20070197610A1 (en) * 2004-03-16 2007-08-23 Janssen Pharmaceutica N.V. Benzisoxazoles
WO2007006003A2 (en) 2005-07-06 2007-01-11 Sepracor Inc. Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
RU2430913C2 (ru) * 2006-01-06 2011-10-10 Сепракор Инк. Циклоалкиламины в качестве ингибиторов повторного поглощения моноамина
AU2006335174B2 (en) * 2006-01-06 2012-09-06 Sunovion Pharmaceuticals Inc. Tetralone-based monoamine reuptake inhibitors
PT2816024T (pt) 2006-03-31 2017-10-20 Sunovion Pharmaceuticals Inc Aminas quirais
US7884124B2 (en) * 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7579370B2 (en) * 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
US20080082066A1 (en) * 2006-10-02 2008-04-03 Weyerhaeuser Co. Crosslinked carboxyalkyl cellulose fibers having non-permanent and temporary crosslinks
ES2627221T3 (es) 2006-12-28 2017-07-27 Rigel Pharmaceuticals, Inc. Compuestos de heterocicloalquiloxibenzamida N-sustituidos y métodos de uso
JP2010516697A (ja) * 2007-01-18 2010-05-20 セプラコール インク． Ｄ−アミノ酸オキシダーゼ阻害剤
US7902252B2 (en) * 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
KR101581289B1 (ko) 2007-05-31 2015-12-31 세프라코 아이엔시. 모노아민 재흡수 억제제로서 페닐 치환된 시클로알킬아민
CA2716080C (en) 2008-02-20 2016-12-13 Targia Pharmaceuticals Cns pharmaceutical compositions and methods of use
US20100120740A1 (en) * 2008-08-07 2010-05-13 Sepracor Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
US20110034434A1 (en) * 2009-08-07 2011-02-10 Sepracor Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
SG183261A1 (en) 2010-02-11 2012-09-27 Univ Vanderbilt BENZISOXAZOLES AND AZABENZISOXAZOLES AS mgluR4 ALLOSTERIC POTENTIATORS, COMPOSITIONS, AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTION
MX2014005304A (es) 2011-10-31 2015-03-20 Xenon Pharmaceuticals Inc Biaril eter sulfonamidas y su uso como agentes terapeuticos.
KR20140091022A (ko) 2011-10-31 2014-07-18 제논 파마슈티칼스 인크. 벤젠술폰아미드 화합물 및 치료제로서의 그의 용도
AR091112A1 (es) 2012-05-22 2015-01-14 Genentech Inc Benzamidas n-sustituidas como inhibidores de los canales de sodio nav1.7
WO2014008458A2 (en) 2012-07-06 2014-01-09 Genentech, Inc. N-substituted benzamides and methods of use thereof
KR20150131233A (ko) 2013-03-14 2015-11-24 제넨테크, 인크. 치환된 트리아졸로피리딘 및 이의 사용 방법
CN105492430B (zh) * 2013-03-15 2017-10-10 基因泰克公司 取代的苯并噁唑及其使用方法
US9493429B2 (en) 2013-03-15 2016-11-15 Genentech, Inc. Substituted benzoxazoles and methods of use thereof
JP6383418B2 (ja) 2013-11-27 2018-08-29 ジェネンテック， インコーポレイテッド 置換ベンズアミド及びその使用方法
JP2017525677A (ja) 2014-07-07 2017-09-07 ジェネンテック， インコーポレイテッド 治療用化合物及びその使用方法
NZ737536A (en) 2015-05-22 2019-04-26 Genentech Inc Substituted benzamides and methods of use thereof
JP2018526371A (ja) 2015-08-27 2018-09-13 ジェネンテック， インコーポレイテッド 治療化合物及びその使用方法
MA43304A (fr) 2015-11-25 2018-10-03 Genentech Inc Benzamides substitués utiles en tant que bloqueurs de canaux sodiques
JP2019513714A (ja) 2016-03-30 2019-05-30 ジェネンテック， インコーポレイテッド 置換ベンズアミド及びその使用方法
CN105801510A (zh) * 2016-04-08 2016-07-27 李勇 一种治疗抑郁症的药物组合物
WO2018072602A1 (en) 2016-10-17 2018-04-26 Genentech, Inc. Therapeutic compounds and methods of use thereof
JP2020511511A (ja) 2017-03-24 2020-04-16 ジェネンテック， インコーポレイテッド ナトリウムチャネル阻害剤としての４−ピペリジン−ｎ−（ピリミジン−４−イル）クロマン−７−スルホンアミド誘導体
WO2019165290A1 (en) 2018-02-26 2019-08-29 Genentech, Inc. Pyridine-sulfonamide compounds and their use against pain and related conditions
JP2021519788A (ja) 2018-03-30 2021-08-12 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ ナトリウムチャネル阻害剤としての縮合環ヒドロピリド化合物
CN114349690B (zh) * 2022-02-15 2023-04-25 甘肃皓天医药科技有限责任公司 一种多拉韦林中间体合成方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1265824A (de) * 1968-03-28 1972-03-08
SU539522A3 (ru) * 1970-02-05 1976-12-15 Мерк Энд Ко. Инк. (Фирма) Способ получени гидразин- -фенилпропионовой кислоты
US3812187A (en) * 1970-02-05 1974-05-21 Merck & Co Inc Hydrazides
JPS476302Y1 (de) * 1970-06-08 1972-03-04
US5321037A (en) * 1986-12-26 1994-06-14 Sankyo Company, Limited Isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants
IE62276B1 (en) * 1988-03-30 1995-01-25 Sankyo Co "New isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants"
US5116839A (en) * 1989-06-26 1992-05-26 Sankyo Company, Limited Use of isoxazolin-3-one derivatives as antidepressants
US5352688A (en) * 1991-02-14 1994-10-04 The Mount Sinai School Of Medicine Of The City University Of New York Methods for the treatment of bradyphrenia in parkinson's disease
US5750542A (en) * 1993-09-28 1998-05-12 Pfizer Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors
JPH0588630A (ja) * 1991-09-30 1993-04-09 Toshiba Lighting & Technol Corp 表示装置
CA2146755A1 (en) * 1992-10-28 1994-05-11 Kenji Takeda Novel 1,2-benzoisoxazole derivative or its salt and brain-protecting agent comprising the same
US5494908A (en) * 1992-11-23 1996-02-27 Hoechst-Roussel Pharmaceutical Incorporated Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds
NZ291508A (en) * 1994-08-30 1999-07-29 Sankyo Co Isoxazoles; preparation and medicaments
CA2190708A1 (en) * 1995-12-08 1997-06-09 Johannes Aebi Aminoalkyl substituted benzo-heterocyclic compounds
JP5229734B2 (ja) * 2008-11-26 2013-07-03 住化エンビロサイエンス株式会社 木材保存組成物

Also Published As

Publication number Publication date
CZ290961B6 (cs) 2002-11-13
DK0779281T3 (da) 2004-03-08
NO970892D0 (no) 1997-02-27
EP0779281A4 (de) 2000-07-26
CA2198457A1 (en) 1996-03-07
KR970705549A (ko) 1997-10-09
HUT77225A (hu) 1998-03-02
PT779281E (pt) 2004-02-27
CZ59897A3 (en) 1997-07-16
MX9701630A (es) 1997-06-28
AU3266095A (en) 1996-03-22
HU221138B1 (en) 2002-08-28
FI970864A0 (fi) 1997-02-28
ES2208690T3 (es) 2004-06-16
CN1098843C (zh) 2003-01-15
NO308741B1 (no) 2000-10-23
WO1996006837A1 (fr) 1996-03-07
DE69532039T2 (de) 2004-07-08
CN1162957A (zh) 1997-10-22
AU688102B2 (en) 1998-03-05
NZ291508A (en) 1999-07-29
NO970892L (no) 1997-04-29
US5965591A (en) 1999-10-12
EP0779281B1 (de) 2003-10-29
ATE253057T1 (de) 2003-11-15
HK1018878A1 (en) 2000-01-07
RU2140414C1 (ru) 1999-10-27
FI970864A (fi) 1997-04-24
US6096771A (en) 2000-08-01
EP0779281A1 (de) 1997-06-18

Similar Documents

Publication Publication Date Title
DE69532039D1 (de) Isoxazole
ATE286026T1 (de) Amid-derivate und deren medizinische verwendung
NO308744B1 (no) Benzimidazolderivater, deres anvendelse, og farmasøytisk preparat inneholdende disse
AU1282495A (en) Anthranilic acid derivative
ES2056190T3 (es) Derivados de 4(4-fenil-1-piperazinil)fenoles, inhibidores de 5-lipoxigenasa.
NZ330973A (en) Azolobenzazepine derivatives as neurologically active agents
AU4523797A (en) Atherosclerosis treatment
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
PT918776E (pt) Sintese total de acilfulvenos antitumorais
PT1030852E (pt) Derivados de oxazolidinona e composicoes farmaceuticas
EP0779074A4 (de) Wirkstoff zum schutz für organ oder gewebe
NZ334701A (en) Dihydropyrones and use in treating retrovirus infections and diseases
WO1995001170A3 (en) Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders
EP0885891A4 (de) Isoxazol-derivate
EP0889033A4 (de)
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
DE59604901D1 (de) Carbamoylcarbonsäureamide
NO20012443D0 (no) Benzoksazolderivater og legemidler inneholdende disse som aktiv bestanddel
EP0785193A4 (de) Arylthiadiazol-derivate und diese enthaltende antivirale arzneimittel
ES2168119T3 (es) Derivados de quinoxalina para el tratamiento de tinnitus.
MX9708031A (es) Sales de 3-fenil-1,4-dialquil-1,2,4-triazolio y su uso como antidepresivos.
TH18321B (th) สารออกฤทธิ์ต้านตัวรับแทคิไคนินชนิดนอนเพปไทด์

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee